• 1. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 2. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 3. Excitation dependent recombination studies on SnO2/TiO2 electrospun nanofibers?
  Veluru Jagadeesh babu,Sesha Vempati RSC Adv., 2015,5, 66367-66375
• 4. Distinct impact of glycation towards the aggregation and toxicity of murine and human amyloid-β?
  Eunju Nam,Jiyeon Han,Sunhee Choi,Mi Hee Lim Chem. Commun., 2021,57, 7637-7640
• 5. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813

Introduction to (1,5-dimethyl-1H-pyrazol-3-yl)methyl(ethyl)amine (CAS No. 952195-10-7)

(1,5-dimethyl-1H-pyrazol-3-yl)methyl(ethyl)amine, also known by its CAS number 952195-10-7, is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound belongs to the class of pyrazoles, which are known for their diverse biological activities and potential therapeutic applications. The unique structure of (1,5-dimethyl-1H-pyrazol-3-yl)methyl(ethyl)amine makes it an intriguing candidate for various biochemical and pharmacological studies.

The molecular formula of (1,5-dimethyl-1H-pyrazol-3-yl)methyl(ethyl)amine is C₉H₁₆N₃, and its molecular weight is approximately 166.24 g/mol. The compound features a pyrazole ring with two methyl groups at the 1 and 5 positions, and an ethylamine moiety attached to the 3-position of the pyrazole ring. This structural arrangement imparts unique chemical and biological properties to the molecule, making it a valuable tool in the development of novel drugs and therapeutic agents.

Recent research has highlighted the potential of (1,5-dimethyl-1H-pyrazol-3-yl)methyl(ethyl)amine in various therapeutic areas. One notable application is in the field of neurodegenerative diseases. Studies have shown that this compound can modulate specific neurotransmitter systems, particularly those involving serotonin and dopamine. These neurotransmitters play crucial roles in mood regulation, cognitive function, and motor control. By influencing these systems, (1,5-dimethyl-1H-pyrazol-3-yl)methyl(ethyl)amine may offer new avenues for treating conditions such as Parkinson's disease and Alzheimer's disease.

In addition to its neuropharmacological properties, (1,5-dimethyl-1H-pyrazol-3-yl)methyl(ethyl)amine has been investigated for its anti-inflammatory effects. Inflammatory responses are central to many chronic diseases, including arthritis and cardiovascular disorders. Preclinical studies have demonstrated that this compound can inhibit key inflammatory pathways, such as the NF-kB signaling cascade. This inhibition can lead to reduced production of pro-inflammatory cytokines and chemokines, thereby alleviating inflammation and associated symptoms.

The pharmacokinetic profile of (1,5-dimethyl-1H-pyrazol-3-yl)methyl(ethyl)amine is another area of active research. Understanding how this compound is absorbed, distributed, metabolized, and excreted (ADME) is crucial for optimizing its therapeutic potential. Initial studies suggest that it has favorable pharmacokinetic properties, including good oral bioavailability and a relatively long half-life. These characteristics make it a promising candidate for further development as an oral medication.

Safety assessments are an essential part of drug development, and preliminary toxicological studies on (1,5-dimethyl-1H-pyrazol-3-yl)methyl(ethnic)amine have shown promising results. The compound appears to have a low toxicity profile at therapeutic doses, with no significant adverse effects observed in preclinical models. However, more extensive safety evaluations are needed to ensure its long-term safety in human subjects.

The synthesis of (1,5-dimethyl-1H-pyrazol-3-yl)methyl(ethnic)amine has been optimized using modern synthetic techniques. Various methods have been developed to produce this compound efficiently and cost-effectively on a large scale. These synthetic routes typically involve multi-step processes that include the formation of the pyrazole ring followed by functional group modifications to introduce the desired substituents.

In conclusion, (1,5-dimethyl-1H-pyrazol-3-yl)methyl(ethnic)amine (CAS No. 952195-10-7) is a promising compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique structure and biological activities make it a valuable tool for developing new treatments for neurodegenerative diseases, inflammatory disorders, and other conditions. Ongoing research continues to uncover new insights into its mechanisms of action and therapeutic potential, positioning it as a key player in the future of drug discovery and development.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)